 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Carboxylic-ester hydrolases [EC:3.1.1.-]
|
Phosphatases [EC:3.1.3.-]
|
Phosphodiesterases [EC:3.1.4.-]
|
Sulfatases [EC:3.1.6.-]
|
Glycosidases [EC:3.2.1.-]
|
ADP-ribosyl cyclase [EC:3.2.2.6]
|
Aminopeptidases [EC:3.4.11.-]
|
Dipeptidases [EC:3.4.13.-]
|
Peptidyl-peptidases [EC:3.4.14.-]
|
Peptidyl-dipeptidases [EC:3.4.15.-]
|
Metallocarboxypeptidases [EC:3.4.17.-]
|
Serine peptidases [EC:3.4.21.-]
|
CTRB [HSA:1504 440387] [KO:K01310]
|
PRSS [HSA:5644 5645 5646] [KO:K01312]
|
F2 [HSA:2147] [KO:K01313]
|
F10 [HSA:2159] [KO:K01314]
|
PLG [HSA:5340] [KO:K01315]
|
F9 [HSA:2158] [KO:K01321]
|
KLKB1 [HSA:3818] [KO:K01324]
|
KLK [HSA:3816 3817] [KO:K01325]
|
KLK1 [HSA:3816] [KO:K01325]
|
CELA1 [HSA:1990] [KO:K01326]
|
ELANE [HSA:1991] [KO:K01327]
|
C1R [HSA:715] [KO:K01330]
|
C1S [HSA:716] [KO:K01331]
|
CFB [HSA:629] [KO:K01335]
|
CFD [HSA:1675] [KO:K01334]
|
CLPP [HSA:8192] [KO:K01358]
|
MASP2 [HSA:10747] [KO:K03993]
|
PCSK9 [HSA:255738] [KO:K13050]
|
 D10557 Evolocumab (USAN/INN) <JP/US>
D10335 Alirocumab (USAN) <US>
D11931 Inclisiran (USAN/INN)
D12293 Inclisiran sodium (JAN) <JP/US>
D10621 Bococizumab (USAN/INN)
D11398 Frovocimab (USAN/INN)
|
HTRA1 [HSA:5654] [KO:K08784]
|
LPA [HSA:4018] [KO:K09644]
|
Cysteine peptidases [EC:3.4.22.-]
|
Aspartic peptidases [EC:3.4.23.-]
|
Metallo peptidases [EC:3.4.24.- 3.4.17.-]
|
Threonine peptidases [EC:3.4.25.-]
|
Glutaminase [EC:3.5.1.2]
|
Histone deacetylase [EC:3.5.1.98]
|
Arginase [EC:3.5.3.1]
|
Adenosine deaminase [EC:3.5.4.4]
|
Cytidine deaminase [EC:3.5.4.5]
|
ATPase [EC:3.6.3.-]
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs